Stock data
Arcadia Biosciences, Inc. (RKDA)
Arcadia Biosciences, Inc. (RKDA) reported revenue of US$4.86M and net income of -US$2.34M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$4.86M | — | -US$2.50M | -US$2.34M | — |
| 2024 | US$5.04M | — | -US$3.65M | -US$7.04M | — |
| 2023 | US$4.45M | — | -US$6.10M | -US$13.98M | — |
| 2022 | US$7.42M | — | -US$14.01M | -US$15.38M | — |
| 2021 | US$6.78M | — | -US$35.53M | -US$14.66M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$1.44M | -US$6.27M | — |
| 2026-03-31 | US$1.10M | -US$4.38M | — |
| 2025-12-31 | US$0.90M | -US$1.34M | — |
| 2025-09-30 | US$1.30M | US$0.86M | — |
| 2025-06-30 | US$1.46M | -US$4.46M | — |
| 2025-03-31 | US$1.20M | US$2.60M | — |
| 2024-12-31 | US$1.22M | -US$4.06M | — |
| 2024-09-30 | US$1.54M | -US$1.61M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.